Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine intervention in TPOAb-negative pregnant women with mildly elevated TSH
ChiCTR2100042002Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levothyroxine sodium in thyroid disease (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Fetal loss. Started Jan 2021; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
thyroid disease
Beyond the preview
Go deeper on ChiCTR2100042002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042002.